the three days of training between June 4^th - 6^th were well attended

Berlin, Germany – June 28, 2019: ANT Neuro hosted the first nëo DP training near our Corporate Headquarters in Berlin and was joined by more than 20 participants from all over Europe. The three tracks of sessions ranged from collaborative business discussions, market strategy, product training and product specific technical training.  

The CE marked version of the nëo product was officially released in January of 2019 and has gained the interest of distribution partners in Europe, Asia and Latin America. nëo is an intuitive aEEG (CFM) monitor for the neonatal ICU, with the vision to improve clinical care of preterm and critically ill term newborns. nëo offers a modern and easy-to-use solution for monitoring the brain function and brain development of the most fragile patients.

nëo saves valuable time for monitoring and diagnosis by enabling quick initiation of aEEG or Cerebral Function Monitoring (CFM) recordings with minimal setup effort. The possibility to use nëo with touchproof electrodes or the waveguard EEG caps specifically designed for neonates reduces complexity of electrode preparation and maximizes efficiency. nëo allows the use of up to 8 referential channels assessment of neurological function. Once monitoring is started, nëo’s interface is optimized for providing an adapted view with only relevant information displayed for all users, be it nurses, bedside staff, neonatologists or pediatric neurologists. This simplifies the collaboration between neonatal caregivers.

Brochure

nëo will be available throughout Europe through a network of distributors. eemagine GmbH is a Berlin (Germany) based provider of high-performance neuro-science and neuro-care solutions for the past 19 years.